Table 1. Correlation between miR-125b expression and clinicopathological profiles.
| |
|
MicroRNA-125b expression |
|
|
|---|---|---|---|---|
| Clinicopathological profiles | n | Low (<median) | High (>median) | P-value |
|
Tumour size (T) | ||||
| T1 | 5 | 1 (20%) | 4 (80%) | P=0.086a |
| T2 | 14 | 5 (36%) | 9 (64%) | |
| T3 | 10 | 8 (80%) | 2 (20%) | |
| T4 |
21 |
11 (53%) |
10 (47%) |
|
| T1+T2 | 19 | 6 (32%) | 13 (68%) | P=0.079b |
| T3+T4 |
31 |
19 (61%) |
12(39%) |
|
|
Regional lymph node metastasis (N) | ||||
| Negative | 33 | 16 (48%) | 17 (52%) | P=0.765a |
| Positive |
17 |
9 (53%) |
8 (47%) |
|
|
Stage classification | ||||
| I | 5 | 1 (20%) | 4 (80%) | P=0.100a |
| II | 6 | 1 (17%) | 5 (83%) | |
| III | 7 | 5 (71%) | 2 (29%) | |
| IV |
32 |
18 (56%) |
14 (44%) |
|
| I+II | 11 | 2 (18%) | 9 (82%) | P=0.037b |
| III+V |
39 |
23 (59%) |
16 (41%) |
|
|
Differentiation | ||||
| Well | 28 | 13 (46%) | 15 (54%) | P=0.776b |
| Moderate+poor | 22 | 12 (55%) | 10 (45%) | |
a
The χ2 test.
b
Fisher's exact test.